Answers are grounded in this paper and cite their sources.
Methodological review details immunocompetent and xenograft systems in murine multiple myeloma, highlighting protocols for systemic and local disease modeling.
Multiple myeloma is an incurable plasma-cell malignancy characterized by osteolytic bone disease and immunosuppression. Murine models of multiple myeloma and myeloma bone disease are critical tools for an improved understanding of the pathogenesis of the disease and the development of novel therapeutic strategies. This review will cover commonly used immunocompetent and xenograft models of myeloma, describing the advantages and disadvantages of each model system. In addition, this review provides detailed protocols for establishing systemic and local models of myeloma using both murine and human myeloma cell lines.
No takes yet. Share an insight, caveat, or question.
Lwin et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: